Pravadoline is a novel analgesic agent whose mechanism of action includes inhibition of cyclooxygenase and cannabinoid receptor agonist activity.
Product Details
| Formula: | C23H26N2O3 |
| |
| MW: | 378.5 |
| |
| CAS: | 92623-83-1 |
| |
| Purity: | ≥98% (TLC) |
| |
| Identity: | Determined by NMR. |
| |
| Appearance: | Off-white solid. |
| |
| Solubility: | Soluble in DMSO. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor: T. E. D'Ambra, et al.; J. Med. Chem.
35, 124 (1992),
Abstract;
Pharmacology of pravadoline: a new analgesic agent: D. R. Haubrich, et al.; J. Pharmacol. Exp. Ther.
255, 511 (1990),
Abstract;
